News
Quality Control North West at Stockport are delighted to announce that we will be replacing our current liquid chromatography mass spectrometer (LCMS) with a brand new state of the art Agilent Ultivo Triple Quadrupole Mass Spectrometer. Installation is due in February 2022 and work is currently in progress to transfer all current methods onto the new system.
The cytotoxic residue monitoring service shall continue as it is now. It is hoped that the new instrument can be utilise...
Read Full Story
NCIVAS stability studies undertaken by QCNW Stockport have been published on the BSAC International Collaborative Drug Stability Testing Forum here.
Following a recent inspection QCNW have successfully transitioned to the updated ISO 17025:2017 standard for accreditation as a testing laboratory. Thanks to all our staff for their hard work in preparing for and facilitating the accreditation inspection.
Following the retirement of Phil Weir, QCNW is delighted to announce that his successor will be Diane Rigge. Diane has been deputy head of the Stockport laboratory over recent years but originally joined QCNW in 1998. Diane officially takes up her post from the beginning of June.
The MHRA has informed QCNW of a change in status of the Stockport Laboratory. As from 13 September 2018, Stockport is registered as a standalone laboratory. Previously it has been part of the Stockport Pharmaceuticals MIA ; QCNW is now removed from that license. This brings our standalone status in line with QCNW Liverpool and has enabled a widening of our scope for testing Veterinary as well as Human Medicines.
We are pleased to announce that Dr Lyndsay Davies has been accepted as a member of the the National NHS Research and Development Committee. Lyndsay will bring significant expertise to the group particularly in the area of testing of biological molecules such monoclonal antibodies. Phil Weir will continue as a member along with Lyndsay for the present.